Telomeres Might Predict Lung Cancer Recurrence
Telomeres are sections of DNA that tell an interesting story about lifespan. Shorter telomeres usually suggest a shorter life -- but new research by a Wilmot lung cancer expert shows that longer telomeres might be a promising biomarker for a recurrence of early stage lung cancer.
When prostate cancer is detected through a screening test and no symptoms are present, logic would say the disease is probably insignificant and the patient can avoid aggressive treatment. Yet statistics tell a different story: 1 in 6 of these men will have higher-risk disease, according to a University of Rochester study published in Frontiers in Oncology.
1/28/2014 | 0 comments
Platelets are known for their role in forming blood clots, but more and more research shows that platelets help control our immune system as well. A study in The Journal of Clinical Investigation suggests a new way in which platelets influence our immune response that could alter the treatment of arthritis, asthma and atherosclerosis.
1/27/2014 | 0 comments
Research led by emergency medicine specialist Jeffrey Bazarian, M.D., M.P.H., was featured in the R&D section of last weekend’s Wall Street Journal.
1/20/2014 | 0 comments
A brain protein, S100B, which may soon be detected by a simple finger-stick blood test, accurately distinguishes a sports-related concussion from sports exertion, according to a study of college athletes in Rochester, N.Y., and Munich, Germany, and published in PLOS ONE by Jeffrey J. Bazarian, M.D, associate professor at the University of Rochester.
1/9/2014 | 1 comment
A URMC study that found that tobacco smoke impairs our body clocks is featured on the cover of the January issue of The FASEB Journal. Scientists believe that the impact of environmental toxins like cigarette smoke on sleep and overall health is an important and growing area of interest.
1/7/2014 | 0 comments